Wealth Enhancement Advisory Services
TELO icon

Wealth Enhancement Advisory Services’s Telomir Pharmaceuticals TELO Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio TELO Stock Details TELO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+12,119
New +$15.8K ﹤0.01% 4248

Other funds holding TELO

PWM
Praetorian Wealth Management Carmel, California $580M AUM 19.43% 1-Year Est. Return
MCM
Morton Capital Management Calabasas, California $731M AUM 20.62% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Wealth Enhancement Advisory Services's TELO Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in Telomir Pharmaceuticals (TELO) in Q2 2026: 12,119 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #4248 among its holdings.

5 funds tracked by Wall St. Rank hold TELO as of Q2 2026.

  • Wealth Enhancement Advisory Services held 12,119 shares of Telomir Pharmaceuticals worth $0 as of Q2 2026.
  • Telomir Pharmaceuticals was a new Wealth Enhancement Advisory Services position in Q2 2026.
  • Telomir Pharmaceuticals made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #4248 holding.
  • 5 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.